Istiratumab

Tax included
Istiratumab (M-6495) is bispecific monoclonal antibody targeting IGF-1R and ErbB3. Istiratumab induces IGF-1R and ErbB3 receptor degradation through the proteasome pathway Istiratumab can be used for research of cancers.
MedChemExpress 
HY-P99672

Data sheet

Size
Multiple sizes
Reactivity
IGF-1R; EGFR
CAS
1509928-04-4